Equitable Trust CO Eli Lilly & CO Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

A detailed history of Equitable Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Equitable Trust CO holds 8,540 shares of LLY stock, worth $6.78 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

8,540

Previous 8,514 0.31%

Holding current value

$6.78 Million

Previous $7.71 Million 1.86%

% of portfolio

0.51%

Previous 0.56%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $20,075 - $24,960	26 Added 0.31%	8,540 $7.57 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $724 - $909	1 Added 0.01%	8,514 $7.71 Million
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $193,649 - $259,075	-327 Reduced 3.7%	8,513 $6.62 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $31,511 - $37,147	-60 Reduced 0.67%	8,840 $5.15 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $76,072 - $104,877	175 Added 2.01%	8,900 $4.78 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $75,409 - $100,830	-215 Reduced 2.4%	8,725 $4.09 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $48,458 - $56,911	156 Added 1.78%	8,940 $3.07 Million
Q4 2022 Feb 21, 2023	SELL	$321.55 - $374.67 $346,952 - $404,268	-1,079 Reduced 10.94%	8,784 $3.21 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $276,615 - $315,232	-933 Reduced 8.64%	9,863 $3.19 Million
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $168,631 - $197,998	-605 Reduced 5.31%	10,796 $3.5 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $62,896 - $78,164	-268 Reduced 2.3%	11,401 $3.27 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $19,561 - $24,276	-87 Reduced 0.74%	11,669 $3.22 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $146,034 - $179,715	-659 Reduced 5.31%	11,756 $2.72 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $55,609 - $71,930	308 Added 2.54%	12,415 $2.85 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $406,856 - $526,694	2,476 Added 25.71%	12,107 $2.26 Million
Q2 2020 Aug 18, 2020	SELL	$136.42 - $164.18 $32,467 - $39,074	-238 Reduced 2.41%	9,631 $1.58 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $146,480 - $181,429	-1,370 Reduced 12.19%	9,869 $1.3 Million
Q3 2019 Nov 19, 2019	BUY	$106.79 - $116.16 $60,870 - $66,211	570 Added 5.34%	11,239 $1.26 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $5,788 - $6,813	-52 Reduced 0.49%	10,669 $1.39 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $8,586 - $10,731	-100 Reduced 0.92%	10,721 $1.15 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $819,149 - $940,128	10,821 New	10,821 $923,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Eli Lilly & CO Transaction History